Alvotech (ALVOW) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Luxembourg, Iceland. The current CEO is Vilhelm Robert Wessman.
ALVOW has IPO date of 2022-06-16, 1,012 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $81.18M.
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.
